Abstract
Idiopathic nephrotic syndrome, which is the most frequent glomerular disease in children, is defined by the combination of nephrotic syndrome and minimal change glomerular disease, with foot process fusion on electron microscopy. No immunoglobulin or complement fraction deposits are seen on immunofluorescent examination. However, in some cases, diffuse mesangial proliferation or focal and segmental glomerulosclerosis may be seen on light microscopy. In addition, immunofluorescent examination sometimes reveals mesangial immunoglobulin deposits found either in isolation or in association with C1q and/or C3 deposits. The most frequently found immunoglobulin is IgM, leading some authors to consider IgM nephropathy as a disease entity (1). IgA deposits have also been found in some patients (2, 3) as well as granular C3 deposits.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cohen, A.H., Border, W.A. and Glassock, R.J. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab. Invest. 38: 610–619, 1978.
Katz, A., Walker, J.F. and Landy, P.J. IgA nephritis with nephrotic range proteinuria. Clin. Nephrol. 20: 67–71, 1983.
Mustonen, J., Pasternack, A. and Rantala, I. The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin. Nephrol. 20: 172–176, 1983.
Habib, R. and Churg, J. Minimal change disease, mesangial proliferation glomerulonephritis and focal sclerosis: individual entities or a spectrum. IN: Nephrology (Ed. R.R. Robinson) Springer Verlag, New York, 1554, pp. 634–644.
Borel, J.F., Gubler, H.U. and Stahelin, H. The biological effects of Cyclosporine A: A new antilymphocyte agent. Agents Actions. 6: 468–475, 1976.
Cohen, D.J., Loertscher, R., Rubin, M.F., Tilney, N.L., Carpenter, C.B. and Strom, T.B. Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann. Intern. Med. 101: 667–682, 1984.
Nelson, P.W. Cyclosporine. Surg. Gynecol. Obstet. 159: 297–308, 1984.
Bunjes, D., Hardt, C., Rollinghoff, M. and Wagner, H. Cyclosporine A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukine 1 and interleukine 2. Eur. J. Immunol. 11: 657–661, 1981.
Hess, A.D., Tutschka, P.J. and Santos, G.W. Effect of Cyclosporine A on human lymphocyte responses in vitro: II induction of specific alloantigen unresponsiveness mediated by nylon wool adherent suppressor cell. J. Immunol 126: 961–968, 1981.
Brouhard, B.H., Goldblum, R.M., Bunce, H. and Cunningham, R.J. Immunoglobulin synthesis and urinary IgG excretion in the idiopathic nephrotic syndrome of children. Int. J. Pediatr. Nephrol. 2: 163–169, 1981.
Giangiacomo, J., Cleary, T.G., Cole, B.R., Hoffsten, P., Robson, A.M. Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal change nephrotic syndrome. N. Engl. J. Med. 293: 8–12, 1975.
Heslan, J.M., Lautie, J.P., Intrator, L., Blanc, C., Lagrue, G. and Sobel, A.T. Impaired IgG synthesis in patients with the nephrotic syndrome. Clin. Nephrol. 18: 144–147, 1982.
Dall’Aglio, P. Minimal change glomerulonephritis and focal glomerulosclerosis: markers and in vitro activity of peripheral blood mononuclear cells. Proc. Eur. Dial. Transplant. Assoc. 19: 673–678, 1982.
Fodor, P., Saitua, M.T., Rodriguez, E., Gonzales, B. and Schlesinger, L. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am. J. Dis. Child. 136: 713–717, 1982.
Matsumoto, K., Osakabe, K., Harada, M. and Matano, M. Impaired cell-mediated immunity in lipoid nephrosis. Nephron 29: 190–194, 1981.
Eyres, K., Mallick, N.P. and Taylor, G. Evidence for cell-mediated immunity to renal antigens in minimal-change nephrotic syndrome. Lancet 1: 1158–1159, 1976.
Minchin, M.A., Turner, K.J. and Bower, G.D. Lymphocyte histogenesis in nephrotic syndrome. Clin. Exp. Immunol. 42: 241–246, 1980.
Mallick, N.P., Williams, R.J., McFarlane, H., Orr, W.M., Taylor, G. and Williams, G. Cell-mediated immunity in nephrotic syndrome. Lancet 1: 507–509, 1972.
Schnaper, H.W. and Aune, T.M. Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J. Clin. Invest. 76: 341–349, 1985.
Lagrue, G., Branellec, A. and Blanc, C. A vascular permeability factor in lymphocyte culture supernatants from patients with nephrotic syndrome. II Pharmalogical and physicochemical properties. Biomedecine 23: 73–75, 1975.
Shalhoub, R.J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2: 556–559, 1974.
Hoyer, P.F., Krull, F. and Brodehl, J. Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet 2: 335, 1986.
Capodicasa, G., De Santo, N.G., Nuzzi, F. and Giordano, C. Cyclosporin A in nephrotic syndrome of childhood: a 14 month experience. Int. J. Pediatr. Nephrol. 7: 69–72, 1986.
Niaudet, P., Habib, R., Tete, M.J., Hinglais, N. and Broyer, M. Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr. Nephrol. 1: 566–573, 1987.
Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C.J. and Khawar, M.R. Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J. Pediatr. 111 (6, part 2): 1056–1062, 1987.
Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C.J. and Khawar, M.R., Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 33: 729–734, 1988.
Brandis, M., Burghard, R., Leititis, J., Zimmerhackl, B., Hildebrandt, F. and Helmcher, U. Cyclosporin A for treatment in nephrotic syndrome. Pediatr. Nephrol. 1: C42, 1987.
Waldo, F.B. and Kohaut, E.C. Therapy of focal segmental glomerulosclerosis with Cyclosporine A. Pediatr. Nephrol. 1: 180–182, 1987.
Brodehl, J., Ehrich, J.J.H., Hoyer, P.F., Lee, I.J., Oemar, B.S. and Wonigeit, K. Cyclosporin A treatment of minimal change nephrotic syndrome and focal segmental glomerulosclerosis in children. Korean J. Nephrol. 6: 26–33, 1987.
Myers, B.D. Cyclosporine nephrotoxicity. Kidney In 30: 964–974, 1986.
Meyrier, A., Simon, P., Perret, G. and Condamin-Meyrier, M.C. Remission of idiopathic nephrotic syndrome after treatment with Cyclosporine A. Br. Med. J. 292: 789–792, 1986.
Lagrue, G., Laurent, J., Belghiti, D. and Robeva, R. Cyclosporin and idiopathic nephrotic syndrome. Lancet 2: 692–693, 1986.
Chan, M.K. and Cheng, I.K.P. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses. Postgrad. Med. J. 63: 757–759, 1987.
Meyrier, A. and Simon P. Treatment of cortical resistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis, In: Advances in Nephrology (Eds. Grunfeld, Maxwell, Bach, Crosnier, Funk Bruntano) Year Book Medical Publishers, Inc. 1988, pp. 127–150.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Niaudet, P., Broyer, M. (1989). Cyclosporin in the Therapy of Idiopathic Nephrotic Syndrome in Children. In: Andreucci, V.E., Fine, L.G., Hatano, M., Kjellstrand, C.M. (eds) International Yearbook of Nephrology 1989. International Yearbooks of Nephrology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1673-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1673-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8934-0
Online ISBN: 978-1-4613-1673-2
eBook Packages: Springer Book Archive